increase (P Ͻ 0.01 vs. control). In conclusion, the cardiodepressive effect of postischemic effluent is COX-2 dependent and protective against Ca 2ϩ overload in the cells.
cyclooxygenase; potassium adenosine 5Ј-triphosphate channels EXPERIMENTAL EVIDENCE INDICATES that negative inotropic mediators are released from the postischemic myocardium during reperfusion (13, 14) . We have previously shown that these substances reduce systolic cell shortening and Ca 2ϩ transients in field-stimulated isolated rat cardiomyocytes. Reduction results from decreased maximal conductance and not from voltage-and time-dependent gating of the L-type Ca 2ϩ channel (14) . With the use of a double heart model, a marked decrease in left ventricular (LV) pressure (LVP) and in LV peak positive (LV dP/dt max ) and LV peak negative (LV dP/dt min ) coronary perfusion pressure was measured in heart II perfused with the postischemic effluent of heart I (13). The negative inotropic substances do not modulate tissue concentrations of cAMP and cGMP and do not affect the activities of cAMP-dependent protein kinase A and protein kinase C (14) . Using a model of two sequentially perfused rat hearts, we demonstrated that these cardiodepressive mediators are not released from coronary endothelial cells (42) . Until now, the precise mechanisms of these negative inotropic substances have remained unknown.
Ischemia and reperfusion are associated with an increase in arachidonic acid levels in cell membranes and induce profound alterations in myocardial eicosanoid generation (6, 37) . Arachidonic acid is converted by cyclooxygenase (COX) to prostaglandin H 2 (PGH 2 ), which in turn is the precursor of further prostaglandins and thromboxanes. There is evidence that COX is involved in changes of myocardial metabolism after ischemia. A concentration of prostaglandins in cells increases under postischemic conditions (27) . An inhibition of COX by indomethacin leads to a reduction in cardioprotection after ischemia (5) . It has been speculated that a yet unknown cardioprotective factor is metabolized by COX. There are two different isoforms of COX, designated as COX-1 and COX-2. COX-1 is constitutively expressed, whereas COX-2 is inducible as an immediate early gene by various stress factors. Expression of COX-2 is intensified after cell damage (22, 33, 45) as well as after ischemia (1, 38) .
Interference with potassium (ATP) channels in cardiomyocytes is another mechanism by which arachidonic acid metabolites may modulate postischemic myocardial contractility (26) . Ischemic conditions induce the opening of ATP channels in cardiomyocytes. There is evidence that potassium efflux improves cardiac function during reperfusion and that eicosapentaenoic acid is capable of opening the channels (2, 20, 26) . The opening of potassium (ATP) channels has a negative inotropic effect on cardiac tissue (25, 28, 49) .
Since alterations in arachidonic acid metabolism are intensively involved in the modulation of myocardial contractility after ischemia, in the present study we investigated in isolated rat cardiomyocytes whether the above-described negative inotropic substances are synthesized via arachidonic acid metabolism.
MATERIALS AND METHODS

Collection of Postischemic Effluent From Isolated Rat Hearts
Rat hearts were perfused at a constant flow (10 ml/min) with Krebs-Henseleit buffer (KHB) in an open Langendorff system, as previously described (14) .
The perfusion phase lasts 30 min; the control effluent (nonischemic effluent) was obtained during the final 30 s. Hearts were then subjected to 10 min of global stop-flow ischemia. Hearts were kept warm during this ischemic period. The isolated hearts were then subsequently reperfused. At the onset of reperfusion, postischemic effluent containing the negative inotropic mediators was collected over a period of 30 s (5 ml). The nonischemic and postischemic effluents were immediately used for in vitro experiments. Both nonischemic and postischemic effluents were diluted (1:4) with KHB (14) .
Isolation of Rat Ventricular Myocytes
The ventricular myocytes were isolated in an open Langendorff system, as described elsewhere (14) . Rat hearts were perfused with oxygenated Ca 2ϩ -free KHB (37°C, pH 7.4) containing (in mmol/l) 110 NaCl, 2.6 KCl, 1.2 KH 2PO4, 1.2 MgSO4, 25 HEPES, and 11 glucose. After 3 min, hearts were perfused with KHB that contained 30 mol/l Ca 2ϩ and collagenase type II (355 U/ml). After 30 min of recirculation and collagenase digestion, hearts were minced and incubated for 15 min in the same solution. The cell suspension was filtered through a nylon sieve and then centrifuged at 43 relative centrifugal force for 1 min to separate cardiomyocytes from fibroblasts. The following washing phases increased Ca 2ϩ , in two steps, to 200 and 500 mol/l.
Intact cells were collected using a Fuchs-Rosenthal chamber. Cells were considered intact if they exhibited the typical rod-shaped morphology with no blebs or granulation. Typically, about 2 ϫ 10 6 cells were obtained per rat heart, 95% of them being intact. The cells were then plated on four-well-chamber glass slides (Nunc, Naperville, IL) that had been coated with 10 g/ml of laminin. The chambers were incubated for 1 h at 4°C. Per chamber, 5,000 cells in 600 l were filled in and subsequently incubated for 2 h at 4°C. The buffer was exchanged, and cells were stained with a solution containing 0.1% dimethyl sulfoxide (DMSO), 0.025% pluronic F-127, 0.2% BSA, and 5 mol/l fura-2 AM. Cells were incubated for 10 min at room temperature on an orbital shaker with oscillation of 20 rpm. Afterward, the incubated cells were washed twice with 500 l KHB.
Measurement of Ca 2ϩ Transients and Systolic Cell Shortening
During the experiment, cardiomyocytes were superfused with experimental buffer at a flow rate of 2 ml/min and kept at room temperature to minimize the cell leakage of fluorescent probes. Postischemic and nonischemic effluents were likewise superfused in this manner, with stimulation by electrodes at a stimulation frequency of 1 Hz and with 5-ms pulse duration, and at a voltage of 12 V, with these conditions constant throughout the entire experiment (Myopacer, Ionoptix). A system consisting of a fluorescence microscope (Leica, DM-IRB) and a high-resolution camera (Myocam, Ionoptix) enabled analysis of both systolic cell shortening and Ca 2ϩ transient per chamber. Cells were examined with a ϫ20 immersion-oil objective. Ca 2ϩ -dependent fluorescence was measured by use of a laser with 6-mW excitation at 360 nm and 380 nm. Emitted light was detected at wavelengths over 515 nm. Changes in Ca 2ϩ concentration were measured as changes in relative fluorescence of fura-2 AM. The difference between systolic and diastolic Ca 2ϩ concentration was measured as the percent change in the ratio of fluorescence at excitation wavelengths of 360 nm to 380 nm. Changes in the Ca 2ϩ transients after superfusion with postischemic or nonischemic effluents were measured as an increase or decrease of percent change in ratio.
For the experiments, cells were used that demonstrated rectangular morphology and that contracted without interruption. A Ca 2ϩ transient was required to show constant values over a period of 2 min. In the experiments, cardiomyocytes were used to show at least 15% contractility and 25% change in ratio at baseline. Testing took place in preceding experiments to determine whether baseline values for contractility and Ca 2ϩ transients were affected by preincubation with the various inhibitors used in this study.
We carried out detection under basal conditions, after which we superfused 2 ml of substances (e.g., postischemic and nonischemic effluent in 1:4 dilution). We next performed acute measurements immediately, which were repeated after 120 s (2 min) and a further 170 s (5 min). Measurements took place over 10 s.
In a further series of experiments, cells were preincubated with the nonselective COX inhibitor indomethacin (5 mol/l), the selective COX-2 inhibitors NS-398 (0.25 mol/l) and lumiracoxib (0.1 mol/l), the selective COX-1 inhibitor SC-560 (0.25 mol/l), and the nonselective potassium (ATP) channel inhibitor glibenclamide (1 mol/l). These inhibitors did not affect the baseline of Ca 2ϩ transients or systolic cell shortening in the concentrations applied.
Detection of COX-2 and COX-1 in Adult Cardiomyocytes
Adult rat cells were plated into laminated six-well plates. After 2 h, the cells were stained with fura-2 AM. For cell lysis, radioimmunoprecipitation assay (RIPA) buffer (Santa Cruz) was used, with additions of 10 l of protease inhibitor, PMSF, and sodium orthovanadate per 1 ml RIPA buffer. Protein quantification took place with a BCA protein assay kit (Pierce). RAW 264.7 lysate (mouse leukemia monocyte macrophage cell line; Santa Cruz) was used as a positive control for COX-2. Samples were mixed 1:1 with 2ϫ sample buffer (Santa Cruz), which were then incubated at 95°C for 3-5 min and run on 10% SDS polyacrylamide gel. Total protein (40 g) per lane were taken for SDS-PAGE. The proteins were transferred onto membranes (Hybond ECL, Amersham) and subjected to immunoblot analysis. Membranes were then blocked for 1 h at room temperature in blocking solution (5 g milk powder diluted in 1 ml 1ϫ TBS-0.1% Tween). Membranes were subsequently incubated overnight with goat anti-COX-2 (0.5 g/ml, Cayman Chemicals) or mouse anti-COX-1 (Cayman Chemicals), diluted in 5% BSA-0.1% Tween 20 in 1ϫ TBS. Membranes were washed and incubated for 90 min at room temperature with secondary antibody bovine anti-goat IgG or bovine anti-mouse IgG, both coupled to horseradish peroxidase at a dilution of 1:5,000 in washing buffer. Proteins were revealed by chemiluminescence with the use of the chemiluminescence kit Super Signal West Pico (Pierce).
Detection of COX-2 in Whole Adult Rat Hearts
Hearts of adult rats were isolated, and protein was extracted. Therefore, hearts were minced and frozen at Ϫ80°C. After 2 days, heart pieces were minced again in liquid nitrogen to obtain very small pieces for production of homogenates and to avoid thawing. Homogenates were produced in lysis buffer (RIPA buffer, Santa Cruz). After centrifugation at 14,000 rpm and 4°C for 15 min, protein extracts were tested for COX-2 expression with Western blot analysis.
In accordance with the collection of postischemic and nonischemic effluent, protein extraction and analysis of COX-2 expression were performed in hearts perfused for 30 min only (control) or perfused for 30 min and subjected to 10 min of global stop-flow ischemia and reperfused for 30 s. COX-2 expression was additionally analyzed after a reperfusion period of 3 and 5 h after ischemia. Control hearts (nonischemic hearts), accordingly, were perfused for a total period of 3.5 and 5.5 h before analyzing for COX-2 expression. Analysis of the protein extracts took place under the same experimental conditions as used for analysis of expression of isolated adult cardiomyocytes.
Materials
Various buffers were applied for our experiments. Buffers were sterile filtered and stored at 4°C. Isolated rat cardiomyocytes were resuspended in buffer containing (in mmol/l) 117 NaCl, 2.8 KCl, 0.6 MgCl 2, 1.2 KH2PO4, 1.2 CaCl2, 10.0 HEPES, and 20.0 glucose at pH 7.3. In the Langendorff system, fixed hearts were perfused with buffer containing (in mmol/l) 110 NaCl, 2.6 KCl, 1.2 MgSO 4, 1.2 KH2PO4, 25.0 HEPES, and 11.0 glucose at pH 7.4, before isolation of cells. For production of postischemic effluent, the isolated rat heart was fixed in the Langendorff system and perfused with KHB containing (in mmol/l) 116.4 NaCl, 4.02 KCl, 1.16 MgSO 4, 1.19 KH2PO4, 1.26 CaCl2, 7.0 HEPES, 9.9 glucose, and 24.9 NaHCO3 at pH 7.3-7.5, to permit heartbeat. Substances were purchased from Merck (Darmstadt, Germany), except for MgCl 2, which was supplied by Sigma-Aldrich (Deisenhofen, Germany).
For isolation of adult rat cardiomyocytes and for production of postischemic effluent, female rats were used (albino Wistar rats; Schönwalde; Berlin, Germany). Animals were 49 to 56 days old and had a weight of 180 to 200 g. Rats were anesthetized with thiopental sodium from Byk Gulden (Konstanz, Germany).
For staining intracellular Ca 2ϩ , fura-2 AM was employed from Sigma-Aldrich. Laminin was obtained from Harbor Bio-Products (Norwood, MA). For cell isolation, collagenase type II (Cell Systems) was applied.
For inhibitor experiments, indomethacin, SC-560, NS-398, and glibenclamide were obtained from Sigma-Aldrich. Lumiracoxib was obtained from Novartis Pharma (Nuremberg, Germany). Inhibitors were dissolved in DMSO, provided by Merck.
The investigation conforms with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, Revised 1996), and the protocol was approved by the District Veterinary Office.
Statistical Analysis
The results are expressed as means Ϯ SE for n calculations. The analysis entailed comparisons between and within the groups. Univariate post hoc analyses were performed in the form of MannWhitney U-tests and Wilcoxon tests after overall testing. Accounts for multiple comparisons were carried out using the sequentially rejective Bonferroni-Holm procedure.
RESULTS
To characterize the effects of postischemic and nonischemic effluent (dilution with 1:4 KHB), we performed measurements of Ca 2ϩ transients (difference between systolic and diastolic Ca 2ϩ concentrations) and systolic cell shortening of isolated cardiomyocytes. Nonischemic effluent was used as a negative control and demonstrated no effect (Fig. 1A) . Reduction of Ca 2ϩ transients and systolic cell shortening was clearly evident during superfusion of the isolated cardiomyocytes with postischemic coronary effluent: the negative inotropic effect is shown by a 15 Ϯ 1% reduction of Ca 2ϩ transients and a 25 Ϯ 2% reduction of systolic cell shortening during steady state (P Ͻ 0.001 vs. control).
Metabolism of the Negative Inotropic Substances
Potential role of COX. The assumption that postischemic substances derive from arachidonic acid metabolism prompted us to speculate that the factors are metabolized in the cell by COX to their active form. We accordingly tested the effect of indomethacin, a nonselective inhibitor of COX (8, 24) .
Preincubation of the cells with 5 mol/l of indomethacin completely abolished the negative inotropic effect of postischemic effluent (Fig. 1A) . Fig. 1, B-D . Preincubation of the cells with SC-560 (0.25 mol/l) failed to modulate the negative inotropic effect of postischemic effluent. In contrast, preincubation with NS-398 (0.25 mol/l) and lumiracoxib (0.1 mol/l) totally prevented the effect of postischemic effluent on Ca 2ϩ transients and contractility.
Potential Cardioprotective Effect of the Negative Inotropic Substances
Potential role of potassium (ATP) channels. We tested the effect of the nonselective potassium (ATP) channel-blocking agent glibenclamide (25) , which equally blocks sarcolemmal and mitochondrial potassium (ATP) channels. As shown in Fig. 2 , glibenclamide completely blunted the negative inotropic effect of postischemic effluent (Fig. 2) .
To study the putative protective effect of postischemic effluent on cardiomyocytes under the condition of increased extracellular Ca 2ϩ load, we increased extracellular Ca 2ϩ concentration from 1.2 to 2.4 mmol/l. When compared with the nonischemic effluent, postischemic effluent significantly attenuated intracellular systolic and diastolic Ca 2ϩ increase, thereby suggesting that postischemic effluent protects cardiomyocytes from Ca 2ϩ overload in the cells (P Ͻ 0.01, Fig. 3 ).
COX-2 Expression in Isolated Adult Cardiomyocytes
COX-2 is inducibly expressed in cells (1, 33) . We therefore performed Western blot analysis to investigate whether COX-2 is expressed in isolated cardiomyocytes laminated and stained with fura-2 AM. As shown in Fig. 4 , COX-2 is expressed in the cardiomyocytes used in our experiments. Cells that were not laminated and stained with fura-2 AM demonstrate less expression of COX-2 in Western blot analysis than do cells that were laminated with or without staining with fura-2 AM.
COX-2 Expression in Isolated Whole Rat Hearts
To investigate whether COX-2 expression is induced by 10 min of global stop-flow ischemia, we additionally performed Western blot analysis of protein extracts from whole rat hearts before and after 10 min of global ischemia. Rat hearts basally express COX-2 (Fig. 5A) , and the expression is not upregulated after 10 min of global stop-flow ischemia either after 30 s or 3 h of reperfusion (Fig. 5, A and B) . After a reperfusion period of 5 h, COX-2 is upregulated in postischemic and nonischemic hearts (Fig. 5C ).
DISCUSSION
The present study provides further insights into the mechanisms by which previously described negative inotropic sub- stance(s) released after myocardial ischemia during reperfusion mediate their negative inotropic effects. Our results suggest that these postischemic substance(s) are most likely a product of the arachidonic acid metabolism.
Several studies have shown that eicosanoids, in particular prostaglandins, are generated during myocardial ischemia. Mobert and Becker (27) detected an increase in prostaglandin concentration in cells of guinea pig hearts after ischemia. Synthesis of prostaglandins by COX-2 requires the release of arachidonic acid or epoxyeicosatrienoic acids (EETs) from phospholipids. The main mediator of postischemic effluent released from myocardial tissue is possibly metabolized to its active form by COX-2.
Role of COX-2 in the Negative Inotropic Effect of Postischemic Effluent
Our data indicate a complex signal transduction process initiated by the main mediator of postischemic effluent. COX-2 evidently plays a role in metabolism of postischemic effluent and its effects on cardiomyocytes; the negative inotropic effect of postischemic coronary effluent on Ca 2ϩ transients and systolic cell shortening was completely prevented by preincubation of the isolated cardiomyocytes with the nonselective cyclooxygenase inhibitor indomethacin and the COX-2 inhibitors NS-398 and lumiracoxib. These findings suggest that the main mediator of postischemic effluent is metabolized by COX-2 to its active form, which leads to a reduction of Ca 2ϩ transients and systolic cell shortening. The effects of the postischemic effluent may be attributed to the effects of oxygen free radicals or different proteins such as cytokines. Previous studies, however, have demonstrated that pretreatment of the postischemic effluent with the free radical scavengers superoxide dismutase and catalase, or various proteases as well as heating, does not modulate the effect of the postischemic effluent (13) .
COX-2 metabolizes arachidonic acid to PGH 2 , which is the precursor of further prostaglandins and thromboxanes. COX-2 is not constitutively expressed in cardiomyocytes but is rather induced by various stress factors, e.g., cytokines, mechanical stress factors, or phenomena, that occur during ischemiareperfusion (1, 21, (31) (32) (33) . COX-2 is basally expressed in the cardiomyocytes used in our experiments. The expression is assumably upregulated due to the preparation process and during lamination of cells for fluorescence microscopy (Fig. 4) .
Several studies demonstrate that COX-2 is upregulated in preconditioned myocardium and that this phenomenon plays an essential role in ischemic preconditioning. COX-2 is accordingly discussed as an important factor of heart protection in the late phase of ischemic preconditioning (4, 23, 40, 48) . COX-2 selective inhibitors interfere with protective effects in the late phase of ischemic preconditioning (40) . In the isolated rat hearts used in our experiments, we were not able to detect upregulated COX-2 expression in Western blot analysis after 10 min of global ischemia. Detection of upregulated COX-2 expression in Western blot analysis after induction by various stress factors (e.g., after ischemia) is normally possible at the earliest after 3 h (3, 10). We therefore perfused rat hearts for 3 h after subjection to 10 min of global stop-flow ischemia in the open Langendorff system and conducted Western blot analysis of the protein extracts. We did not detect upregulated COX-2 expression in these hearts. A longer reperfusion period of the rat hearts leads to intensified COX-2 in the ischemic and control heart, most likely due to myocardial stress (e.g., myocardial edema formation) caused by longer perfusion periods of the isolated hearts (Fig. 5C ).
Cardioprotective Effect of Postischemic Effluent
To further elucidate the pathophysiological role of these negative inotropic substance(s), we increased extracellular Ca 2ϩ concentration to simulate Ca 2ϩ overload. Cardiac ischemia-reperfusion injury is associated with Ca 2ϩ overload in the cardiomyocytes (15, 19, 43, 47) . Ca 2ϩ overload is limited by ischemic preconditioning (43, 47) . As shown in Fig. 3 , postischemic effluent significantly reduced intracellular diastolic and systolic Ca 2ϩ increase, whereas incubation of cells with the nonischemic effluent (control) had no influence on intracellular diastolic and systolic Ca 2ϩ concentration. Accordingly, from a teleological point of view, we speculate that one important function of the negative inotropic substance(s) is to protect cardiomyocytes against Ca 2ϩ overload after ischemia during reperfusion.
The negative inotropic effect of postischemic effluent is antagonized by glibenclamide, which is an antidiabetic sulfonylurease and an inhibitor of sarcolemmal and mitochondrial potassium (ATP) channels. This finding suggests that potassium (ATP) channels play a role in the negative inotropic effect of postischemic effluent. The opening of potassium (ATP) channels occurs during the repolarization phase of the action potential. The efflux of potassium ions returns the cells to the resting potential. In cardiac tissue, the opening of potassium (ATP) channels by various potassium channel openers has a negative inotropic effect on the cells (25, 28, 49) . Gliben- clamide specifically antagonizes the negative inotropic effects of potassium channel openers in cardiac tissue (36) . Under ischemic conditions, potassium (ATP) channels are opened, which in turn elicits a decrease in action potential duration (12) . Various studies show that the potassium (ATP) channel is influenced by substances released from COX metabolism. PGE 2 has an activating effect on potassium (ATP) channels through E-prostanoid (EP) receptor type 2 (EP 2 ) in cultured interstitial cells of Cajal from murine small intestine (7). Aimond et al. (2) describe a group of potassium (ATP) channels in the hearts of mice and rats that are regulated by intracellular acidose, free fatty acids, and arachidonic acids. Other studies provide evidence that potassium (ATP) channels are opened by EETs (26) .
The opening of potassium (ATP) channels during ischemia likewise has a cardioprotective effect and is associated with ischemic preconditioning (9) . The protective effects persist into the reperfusion phase following prolonged ischemia (17) . Substances released from arachidonic acid metabolism show significant cardioprotective effects in several studies (29, 35) . In a recent canine study, 11,12-EET and 14,15-EET demonstrate significant cardioprotective effect via activation of cardiac potassium (ATP) channels (30) . It has been shown that prostacyclin attenuates myocardial ischemia-reperfusion injury via EP 3 prostaglandin receptors by the opening of potassium (ATP) channels (39) . Our findings suggest that the active form of the main mediator in postischemic effluent that is obviously metabolized by COX-2 has an activating effect on potassium (ATP) channels, which leads to a decrease in systolic cell shortening and in Ca 2ϩ transients and therefore has a negative inotropic effect. Cellular mediation perhaps takes place in this context, by means of binding to EP receptors.
Study Limitation
Despite our findings, the identity remains unknown of the mediators that influence Ca 2ϩ metabolism and the contractility of cardiomyocytes. The results of the present study suggest that the active form of the main mediator of postischemic effluent is synthesized by COX-2.
Various stress forms induce enhanced expression of COX-2, e.g., growth factors, cytokines, endotoxins, and mechanical stress (21, 31, 32) . The fact that we detected COX-2 expression by Western blot analysis in the freshly isolated cardiomyocytes of our study is most likely due to the isolation and preparation process of cells for fluorescence microscopy. A reperfusion period of rat hearts after ischemia leads to intensified COX-2 expression in postischemic and nonischemic (control) hearts, since COX-2 is nonspecifically induced, most probably due to myocardial stress (e.g., myocardial edema formation) caused by perfusion in the Langendorff system.
Further experiments are necessary to clarify whether the main mediator in the postischemic effluent mediates its effect in the cell by binding to EP receptors.
Conclusion
The present study suggests that negative inotropic substance(s) are released from isolated hearts after ischemia during reperfusion and are metabolized to their active form via a COX-2-dependent metabolic pathway. These substances induce a decrease in Ca 2ϩ transients via the opening of potassium (ATP) channels and protect cardiomyocytes against Ca 2ϩ overload.
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